IMMUSE® Lactococcus lactis strain Plasma

Unique Postbiotic for Immune Support

IMMUSE®, a novel postbiotic (non-viable probiotic), is the first lactic acid bacteria that been clinically researched to directly activate pDC (plasmacytoid dendritic cells), a rare subset of immune cells, to provide comprehensive innate and adaptive immune support.*

Researched by Kirin and offered by Kyowa Hakko Bio Co., Ltd., leaders in fermentation technology, IMMUSE® has been shown in 29 studies, including 14 human trials to:

  • Provide clinically researched immune support*
  • Activate the immune system via pDC*
  • Proactively support the immune system*
  • Stimulate body’s natural defenses*

For more information, please visit

*This information is only intended for business-to-business use. It must not be passed to the final consumer of your products. The information contained herein is based on our current knowledge and contains scientific, quality, and technical information to help our trade customers understand more about our ingredients and the science behind them. The statements have not been approved by the European Food Safety Authority or the European Commission. It is your responsibility to comply with all relevant EU and national laws when issuing commercial communications about your finished products.